Company Filing History:
Years Active: 2002-2015
Title: Max Rey: Innovator in Pharmaceutical Processes
Introduction
Max Rey is a notable inventor based in Wallisellen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing 3-benzazepines. With a total of 5 patents to his name, Rey's work has implications for treating central nervous system disorders.
Latest Patents
One of Rey's latest patents focuses on processes for preparing 3-benzazepines and their salts. These compounds are recognized for their potential as serotonin (5-HT) receptor agonists, which can be beneficial in treating conditions such as obesity. His innovative approaches in this area highlight the importance of his research in addressing critical health issues.
Career Highlights
Throughout his career, Max Rey has worked with prominent companies in the pharmaceutical industry. Notable among these are Arena Pharmaceuticals, Inc. and Biocryst Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in drug development.
Collaborations
Max Rey has collaborated with several esteemed professionals in his field. Among his notable coworkers are Beverly Lynn Wolgast and Charles A. Gilson, III. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Max Rey's contributions to the pharmaceutical industry through his innovative processes and collaborations underscore his role as a significant inventor. His work continues to pave the way for advancements in treatments for central nervous system disorders.